UP - logo
E-resources
Peer reviewed Open access
  • Circulating Endothelial Cel...
    Guervilly, Christophe; Burtey, Stephane; Sabatier, Florence; Cauchois, Raphaël; Lano, Guillaume; Abdili, Evelyne; Daviet, Florence; Arnaud, Laurent; Brunet, Philippe; Hraiech, Sami; Jourde-Chiche, Noémie; Koubi, Marie; Lacroix, Romaric; Pietri, Léa; Berda, Yaël; Robert, Thomas; Degioanni, Clara; Velier, Mélanie; Papazian, Laurent; Kaplanski, Gilles; Dignat-George, Françoise

    The Journal of infectious diseases, 12/2020, Volume: 222, Issue: 11
    Journal Article

    Abstract Beside the commonly described pulmonary expression of the coronavirus disease 2019 (COVID-19), major vascular events have been reported. The objective of this study was to investigate whether increased levels of circulating endothelial cells (CECs) might be associated with severe forms of COVID-19. Ninety-nine patients with COVID-19 were enrolled in this retrospective study. Patients in the intensive care units (ICU) had significantly higher CEC counts than non-ICU patients and the extent of endothelial injury was correlated with putative markers of disease severity and inflammatory cytokines. Together, these data provide in vivo evidence that endothelial injury is a key feature of COVID-19.